Restenosis: delineating the numerous causes of drug-eluting stent restenosis.
about
Bioresorbable scaffolds for percutaneous coronary interventionsBioresorbable scaffolds: a new paradigm in percutaneous coronary interventionIndirubin and Indirubin Derivatives for Counteracting Proliferative DiseasesPerioperative management of patient with intracoronary stent presenting for noncardiac surgeryA spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cellsCase scenario: a patient on dual antiplatelet therapy with an intracranial hemorrhage after percutaneous coronary interventionHigh-risk percutaneous coronary intervention in a patient with a single coronary artery presenting as STEMI and cardiogenic shock.Stress testing after percutaneous coronary interventions: a population-based study.Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysisUltra-thin strut cobalt chromium bare metal stent usage in a complex real-world setting. (SOLSTICE registry).Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells.Clinical Coronary In-Stent Restenosis Follow-Up after Treatment and Analyses of Clinical Outcomes.Amphiphilic macromolecule nanoassemblies suppress smooth muscle cell proliferation and platelet adhesionChest Pain with Normal Thallium-201 Myocardial Perfusion Image - Is It Really Normal?Image-based quantification of 3D morphology for bifurcations in the left coronary artery: Application to stent design.The inhibition of calpains ameliorates vascular restenosis through MMP2/TGF-β1 pathway.The outcomes of patients with very small coronary artery disease treated with thin strut cobalt chromium bare metal stents: an observational study"The scaffolding must be removed once the house is built"-spontaneous coronary artery dissection and the potential of bioresorbable scaffolds.Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention - real life assessment.Pivotal Cytoprotective Mediators and Promising Therapeutic Strategies for Endothelial Progenitor Cell-Based Cardiovascular Regeneration.Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection.Future potential biomarkers for postinterventional restenosis and accelerated atherosclerosis.Bioresorbable scaffolds in the treatment of coronary artery disease.Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).Healing arterial ulcers: Endothelial lining regeneration upon vascular denudation injury.Treatment of coronary artery in-stent restenosis.The role of Hippo/yes-associated protein signalling in vascular remodelling associated with cardiovascular disease.Resistant in-stent restenosis in the drug eluting stent era.Knuckle technique guided by intravascular ultrasound for in-stent restenosis occlusion treatment.Diagnosis and management challenges of in-stent restenosis in coronary arteries.The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis.Immersive visualization for enhanced computational fluid dynamics analysis.Murine model of femoral artery wire injury with implantation of a perivascular drug delivery patch.Thrombin-Induced Platelet-Fibrin Clot Strength Identified by Thrombelastography: A Novel Prothrombotic Marker of Coronary Artery Stent Restenosis.Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry.Reproducible Arterial Denudation Injury by Infrarenal Abdominal Aortic Clamping in a Murine Model.Current concepts on coronary revascularization using BRS in patients with diabetes and small vessels disease.Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.Black hole restenosis after drug-eluting stent implantation for in-stent restenosis: potential mechanism and optimal strategy.Regulation of mitochondrial morphology by positive feedback interaction between PKCδ and Drp1 in vascular smooth muscle cell.
P2860
Q21972838-6E19C403-41A6-469A-98E2-027E30502913Q26766579-341DD985-330F-4C8A-A496-9E20FB936A58Q26784341-F539DE5F-E708-4A5D-95F3-FBDD2758E533Q28075834-0ADF5F13-F00C-4FB8-9FC1-FFAAF607FF6DQ28818785-C27315E3-9D67-4482-99F9-C284B4A3F3FAQ30371026-93E2225C-C9BF-4636-B4F0-5883797B247EQ33166122-E88CB8C4-2641-4BA7-8510-908BD29F0855Q33874626-D7E48156-01A4-4B29-8AB1-9931F9061E33Q34312812-B11D928A-75C8-4903-9473-4D6698CCF25CQ35044653-8ABAE1A5-4DE0-4B8D-B540-D66CA6EB839EQ35776368-DBA46E88-BC95-485D-AFDE-594E68CF8F1AQ35830197-8F87ADB4-F32C-4D34-B48A-9F989549F09FQ36586068-603C125E-B3AE-4FB7-A0E2-56A1A11FDB1FQ36946116-21712036-DC0B-4E65-91F8-90C37ADFB3DCQ36978589-30A6ACE3-77BA-464A-8C50-11E6EFF6E71EQ37121807-29B2FAF7-5845-4217-92DA-B84080DBBCEEQ37289899-FB1EB3A4-CD59-48D1-AA82-B1FE468D8CFFQ37411195-EB6F88A0-AB7A-48E4-8E1F-6F0FD4E2E047Q37463805-FF217116-8CE3-4997-8B28-0492B4356ED9Q37549578-599C547F-FED9-49BF-91AB-B1EEA53113CFQ37648449-362667BC-5C9E-421C-BF0C-86E27EB6FF7DQ37980498-1DB3EF35-57E2-4791-AAC7-8AD9881CD3CEQ38105546-75E23282-A26D-417E-AB0B-95D040E1A6D3Q38372442-5CEFBC38-5B37-46D4-BFB4-CBB7063F7B30Q38532954-CAFEB926-091F-48DE-B093-B45566590D76Q38766516-7C439F32-1995-456F-A556-928A6AC36FDDQ39215596-27118E32-B034-406E-9937-526985A1F026Q40752196-D2237BF2-EBF6-42A9-A55F-4BB60DE9387CQ41108036-645CE1D4-0DDB-4C7E-A3FD-D58EF0EFFD51Q41608247-5239D9F9-3ECD-4FA2-A4D8-AA292A480078Q42284707-25A02E23-30DD-4BF0-BDA9-42521BA0CDDCQ42555380-48301424-D4A8-445C-9E9C-101EA70721FBQ42557991-C3387866-2B4C-4824-B972-68BAD81B3366Q45026344-ED28D9D0-A930-4FE1-AD6F-3F033CEC860DQ46093469-08CD2C8C-D890-499A-9053-51264C4BC13DQ46286249-A055E8D1-EFAA-4BAE-9FC2-BCBD29873B43Q47999843-D7BEF189-EEBE-4062-AA10-CD1A9524C9B9Q48199206-9EE71795-45ED-4A20-BC38-F85053AFEC80Q51076283-C009DA3E-3406-421D-9C73-539AAFF6105EQ53003922-75D87FCF-637F-4425-A8A2-B49835473404
P2860
Restenosis: delineating the numerous causes of drug-eluting stent restenosis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Restenosis: delineating the numerous causes of drug-eluting stent restenosis.
@en
Restenosis: delineating the numerous causes of drug-eluting stent restenosis.
@nl
type
label
Restenosis: delineating the numerous causes of drug-eluting stent restenosis.
@en
Restenosis: delineating the numerous causes of drug-eluting stent restenosis.
@nl
prefLabel
Restenosis: delineating the numerous causes of drug-eluting stent restenosis.
@en
Restenosis: delineating the numerous causes of drug-eluting stent restenosis.
@nl
P1476
Restenosis: delineating the numerous causes of drug-eluting stent restenosis.
@en
P2093
Bill D Gogas
Vasim Farooq
P304
P356
10.1161/CIRCINTERVENTIONS.110.959882
P577
2011-04-01T00:00:00Z